Dana-Farber ✓

@DanaFarber · Boston, Massachusetts · joined 30 Jun 2008

Dana-Farber Cancer Institute - a leading center for expert, compassionate cancer care and advanced research. Appts: 877-442-3324 | https://t.co/HvCwkLltic

112 362Followers

8 912Following

34 959Posts total

72.2KViews on collected posts

Against accounts of the same size

4 posts from the last 90 days, next to the 100K–1M follower range. below its peers on both reach and engagement.

Median views2 830this account21 891median for 100K–1M

Reach, %2.52%this account6.81%median for 100K–1M

Engagement, %0.45%this account1.14%median for 100K–1M

Metric	This account	Median for 100K–1M	Ratio
Median views per post	2 830	21 891	0.13×
Reach (views ÷ followers)	2.52%	6.81%	0.37×
Engagement rate	0.45%	1.14%	0.39×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

61K2 Jun

3.3K24 Aug

3.7K26 Aug

1.8K27 Aug

2.4K1 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.71%2 Jun

0.46%24 Aug

2.24%26 Aug

0.44%27 Aug

0.34%1 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.14%.

What the audience does

Likes71.8%905 in total

Reposts16.4%207 in total

Replies1.2%15 in total

Quotes2.2%28 in total

Bookmarks8.3%105 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

Join Ursula A. Matulonis, MD, of @DFCIGynOnc and other expert guests in exploring recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Watch the @OncLive series here: https://t.co/W6PqmqWJFP 2.4K views · 7 likes · 1 reposts · 0 replies 01 Sep 2026 Join experts in radiation oncology, medical physics, healthcare operations, and cancer center leadership for a multidisciplinary symposium on the emerging role of upright proton therapy. Register before September 4 for early bird pricing: https://t.co/YLBBQpMZaK https://t.co/vWEy 1.8K views · 6 likes · 2 reposts · 0 replies 27 Aug 2026 The @FDA has approved daraxonrasib for adult patients with previously treated metastatic pancreatic cancer. The approval is based primarily on results from the Dana-Farber-led RASolute 302 trial showing daraxonrasib nearly doubled median overall survival versus chemotherapy. ht 3.7K views · 61 likes · 16 reposts · 5 replies 26 Aug 2026 We’re pleased to share that Sonal Gandhi has been hired as Senior Vice President (SVP) of Campus Operations and Infrastructure, responsible for a broad portfolio which includes strategic oversight and excellence of facilities operations, capital construction, real estate, public 3.3K views · 15 likes · 0 reposts · 0 replies 24 Aug 2026 A historic moment at #ASCO26: more than 9,000 oncologists rose for three standing ovations as Brian Wolpin, MD, MPH, Director of the Hale Family Center for Pancreatic Cancer Research, presented promising new Phase 3 results for an investigational treatment for metastatic https:// 61K views · 816 likes · 188 reposts · 10 replies 02 Jun 2026